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Our 1996 study [1] was undertaken to characterize the sec-
ondary structure and the orientation of the KL4 peptide in a
lipid environment, and to relate these data to the known
structural properties of pulmonary surfactant proteins B and
C (SP-B and SP-C).
Using polarized Fourier transform infrared (FTIR) spectros-
copy and CD spectroscopy we unequivocally demonstrated a
helical structure and a transmembrane orientation of KL4 in a
DPPC/PG bilayer. The monolayer model of KL4 proposed by
Cochrane and Revak [2] is partly based on £uorescence data
[2] and Raman spectroscopy data [3] of the peptide in lipid
bilayers. Due to the di¡erences between lipid bilayers and
monolayers, it is di⁄cult to predict how a transmembrane
stretch of 21 residues with charged residues distributed around
the helical circumference can be accommodated in a lipid
monolayer. No attempt was made in our study to relate the
orientation of KL4 in a lipid bilayer to the orientation in a
lipid monolayer [1]. Further studies are needed in order to
establish the orientation of KL4 in a lipid monolayer. For
example, it has been demonstrated that native SP-C adopts
a transmembrane orientation in a lipid bilayer [4,5] but the
SP-C helix tilt angle to the interface normal changes from
V24‡ in lipid bilayers to V70‡ in DPPC monolayer ¢lms
[6]. We noticed that the orientation of KL4 in a lipid bilayer
closely resembled that of native SP-C [4^7] but contrasted to
the proposed interaction of SP-B with lipid bilayers [8^10],
and therefore suggested that the mechanism of action of
KL4 may be similar to that of SP-C rather than to that of
SP-B. We strongly believe that interactions between SP-B, SP-
C, and synthetic analogues on the one hand and lipid bilayers
on the other are relevant, since these proteins are hydrophobic
and need to be transported in a lipid bilayer environment to
the interfacial monolayer. It should be remembered that the
main location and site of action (bilayer, monolayer, or both)
of SP-B and SP-C in lung surfactant remain to be established.
We also pointed out that the KL4 helix exhibits a mixed
nonpolar/polar surface which is di¡erent from the amphi-
pathic SP-B helices [8,11] and nonpolar SP-C helix [12]. The
spreading of KL4/DPPC/PG/PA vesicles at an air/water inter-
face is rapid, but slower than the spreading of native SP-C/
DPPC/PG/PA vesicles or vesicles composed of an SP-C/bac-
teriorhodopsin hybrid mixed with the same lipids [1]. We sug-
gested that this may be caused by the fact that SP-C exhibits a
‘mobility gradient’ in a phospholipid bilayer, i.e. only the N-
terminal end of the helix contains basic residues that can
interact with the phospholipid head groups [7], while KL4 is
expected to interact similarly with the phospholipid head
groups at both ends of the helix [1].
Studies of the relationships between structure, orientation
and activity of SP-B and SP-C, and their analogues, are nec-
essary in order to understand their roles in the adsorption of
phospholipids to the alveolar air-liquid interface. Such knowl-
edge is also required for rational design of synthetic analogues
of the surfactant proteins.
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